{
  "hits": 306,
  "size": 50,
  "data": [
    {
      "title": "恒瑞医药：碳酸氢钠林格注射液首仿获批上市",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80174696",
      "orgName": "莫尼塔投资",
      "orgSName": "莫尼塔投资",
      "publishDate": "2019-04-18 00:00:00.000",
      "infoCode": "AP201904181320660206",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000250128.张静含",
        "11000294535.仰佳佳"
      ],
      "indvIsNew": "001",
      "researcher": "张静含,仰佳佳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 316,
      "attachPages": 4,
      "encodeUrl": "NJoNeJzjkI7n/Ni3pootE86obq8vAyjaqc4F6GW4wIM=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHANGHAI",
      "authorID": [
        "11000250128",
        "11000294535"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "收入端增长加速，研发力度加大，符合预期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2019-04-18 00:00:00.000",
      "infoCode": "AP201904181320359561",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 661,
      "attachPages": 3,
      "encodeUrl": "NJoNeJzjkI7n/Ni3pootE0FsB+8mzlEvIu6rfddRpiM=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司业绩符合预期，研发大幅增加未来可期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2019-04-17 00:00:00.000",
      "infoCode": "AP201904171320062520",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000172706.李敬雷"
      ],
      "indvIsNew": "001",
      "researcher": "李敬雷",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 994,
      "attachPages": 4,
      "encodeUrl": "g6jC/e2x0VIy0pOARs34UQVL91zSN7VRrZn+PvopsPY=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000172706"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "收入与业绩增长加速，新周期成长趋势明显",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2019-04-17 00:00:00.000",
      "infoCode": "AP201904171319952239",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 748,
      "attachPages": 4,
      "encodeUrl": "g6jC/e2x0VIy0pOARs34UbSax7tBo7gN4Ea65+BEULw=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩增速符合预期，创新龙头执业界牛耳",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2019-02-21 00:00:00.000",
      "infoCode": "AP201902211298741586",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000277542.王晓琦"
      ],
      "indvIsNew": "001",
      "researcher": "王晓琦",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1008,
      "attachPages": 19,
      "encodeUrl": "IAMmH8wyHuXcwBlV6hLpxWO7NXXAENLiUzOWchodiCU=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000277542"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩优秀，创新药进入集中收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000049",
      "orgName": "华鑫证券有限责任公司",
      "orgSName": "华鑫证券",
      "publishDate": "2019-02-19 00:00:00.000",
      "infoCode": "AP201902191297874161",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "47.4000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000259031.杜永宏"
      ],
      "indvIsNew": "001",
      "researcher": "杜永宏",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 779,
      "attachPages": 5,
      "encodeUrl": "fv3AM+X6ILyGA6Jr9r6yxUw1xmPk57J0QV4Pe409T8Y=",
      "sRatingName": "推荐",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000259031"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "肿瘤线表现亮眼，研发投入继续加大，步入创新战略收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2019-02-18 00:00:00.000",
      "infoCode": "AP201902181297557888",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1121,
      "attachPages": 12,
      "encodeUrl": "tC3pC45dEoNW7E6Xva1H3ySqcRu4B63MkQCURTVxjhQ=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "年报业绩稳健，“创新+国际化”助力可持续发展",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2019-02-18 00:00:00.000",
      "infoCode": "AP201902181297546238",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000232234.王冯"
      ],
      "indvIsNew": "001",
      "researcher": "王冯",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 754,
      "attachPages": 5,
      "encodeUrl": "tC3pC45dEoNW7E6Xva1H3/joXhH0jBa9tSYERQFh8yE=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000232234"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩符合预期，新药集中收获期贡献业绩",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2019-02-18 00:00:00.000",
      "infoCode": "AP201902181297541556",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4200000000",
      "predictLastYearPe": "45.3000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000172706.李敬雷"
      ],
      "indvIsNew": "001",
      "researcher": "李敬雷",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 975,
      "attachPages": 4,
      "encodeUrl": "tC3pC45dEoNW7E6Xva1H30SdcEAA4lwuXrPOcgH5ZHE=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000172706"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新获重大突破，推动成长加速",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2019-02-17 00:00:00.000",
      "infoCode": "AP201902171297404950",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 754,
      "attachPages": 4,
      "encodeUrl": "t7L8CAwYI+dxYQ2o2wSP/y+VVZ15roKnaTzK3B6/0XE=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新驱动—恒瑞抗肿瘤创新药即将爆发",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80174696",
      "orgName": "莫尼塔投资",
      "orgSName": "莫尼塔投资",
      "publishDate": "2019-01-22 00:00:00.000",
      "infoCode": "AP201901221287447232",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000250128.张静含",
        "11000294535.仰佳佳"
      ],
      "indvIsNew": "001",
      "researcher": "张静含,仰佳佳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1488,
      "attachPages": 26,
      "encodeUrl": "50GzTIB0qmiZkQtMYafl+ZvfUW3+Crf7EODDFA6Zk2w=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHANGHAI",
      "authorID": [
        "11000250128",
        "11000294535"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2018年三季报点评：新品上市销售拉动三季度收入利润均超预期，创新药步入收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2018-10-31 00:00:00.000",
      "infoCode": "AP201810311227960264",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.1000000000",
      "predictLastYearPe": "52.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋",
        "11000249425.胡偌碧"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋,胡偌碧",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 906,
      "attachPages": 9,
      "encodeUrl": "jSQaV8+iwN4h4cVEGasJmwNJaojJcxFCif/Yh4aAz84=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000210529",
        "11000249425"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "三季报深度跟踪：Q3业绩提速，创新龙头硕果累累",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2018-10-29 00:00:00.000",
      "infoCode": "AP201810291223812070",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3300000000",
      "predictLastYearPe": "43.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000173527.李平祝",
        "11000277542.王晓琦"
      ],
      "indvIsNew": "001",
      "researcher": "李平祝,王晓琦",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1713,
      "attachPages": 18,
      "encodeUrl": "p3w2w4LU4CM/WOkZ+0MWFTAlv5aew4dwXSs8Q1Jofw4=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000173527",
        "11000277542"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司业绩略超预期，季度环比改善仍将持续",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2018-10-26 00:00:00.000",
      "infoCode": "AP201810261222587476",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000172706.李敬雷"
      ],
      "indvIsNew": "001",
      "researcher": "李敬雷",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 965,
      "attachPages": 4,
      "encodeUrl": "d6Bj05MErOfVqhwHgiI03Zm5FeBb8NobxDl6gWuUbNk=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000172706"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司业绩加速增长，重磅产品陆续获批，创新药步入收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2018-10-26 00:00:00.000",
      "infoCode": "AP201810261222511210",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0600000000",
      "predictLastYearPe": "53.5000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 763,
      "attachPages": 9,
      "encodeUrl": "d6Bj05MErOfVqhwHgiI03d6/eusAbMtGKG0cn9OvlI4=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "重磅创新药陆续获批，收入与业绩增长加速",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-10-26 00:00:00.000",
      "infoCode": "AP201810261222327370",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.1000000000",
      "predictLastYearPe": "52.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 660,
      "attachPages": 4,
      "encodeUrl": "d6Bj05MErOfVqhwHgiI03evLkT9o0AyJEAbbYbpYvlQ=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "伊立替康进入优先审评，打开出口转内申报通道",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-10-24 00:00:00.000",
      "infoCode": "AP201810241220118322",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0600000000",
      "predictLastYearPe": "57.1200000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 723,
      "attachPages": 4,
      "encodeUrl": "VVvX22qwOr2f9SskdmL5MHFeue1u8jxdmYsTl8VWaIc=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "Deep dive into flagship drugs",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80044865",
      "orgName": "Deutsche Bank AG",
      "orgSName": "德意志银行",
      "publishDate": "2018-10-22 00:00:00.000",
      "infoCode": "AP201810221218288919",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0200000000",
      "predictLastYearPe": "54.1000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000195635.Jack Hu"
      ],
      "indvIsNew": "001",
      "researcher": "Jack Hu",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "73.9000000000",
      "indvAimPriceL": "73.9000000000",
      "attachType": "0",
      "attachSize": 972,
      "attachPages": 21,
      "encodeUrl": "f0NxdoJrP/H4BZwYijDRDxHMXK/IwrQSYSxwYEFBOyk=",
      "sRatingName": "Buy",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000195635"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "白蛋白紫杉醇顺利上市，新品PD-1获批在即",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2018-09-26 00:00:00.000",
      "infoCode": "AP201809261202086644",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0600000000",
      "predictLastYearPe": "58.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000172706.李敬雷"
      ],
      "indvIsNew": "001",
      "researcher": "李敬雷",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 966,
      "attachPages": 4,
      "encodeUrl": "moRuKluJT4zO/cbeaPtgOxD1Yk5hDop4ojcdBtl4UP0=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000172706"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "动态跟踪报告：紫杉醇（白蛋白结合型）获批，抗肿瘤又添大品种",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-09-07 00:00:00.000",
      "infoCode": "AP201809071190837366",
      "column": "002004006001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0600000000",
      "predictLastYearPe": "60.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 805,
      "attachPages": 4,
      "encodeUrl": "wv7srN4Rz9ZlTsYcV8D1Fh0+Punm3ihx3Q8zib+7mw0=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "动态跟踪报告：首个胰岛素获批临床，进一步丰富糖尿病管线",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-08-27 00:00:00.000",
      "infoCode": "AP201808271183217757",
      "column": "002004006001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0600000000",
      "predictLastYearPe": "64.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 806,
      "attachPages": 4,
      "encodeUrl": "tNKUSvk3jEm3uvpZrNn5sCHhoeHfys10oszO8650NGQ=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药吡咯替尼获批上市点评：千呼万唤始出来",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80174696",
      "orgName": "莫尼塔投资",
      "orgSName": "莫尼塔投资",
      "publishDate": "2018-08-24 00:00:00.000",
      "infoCode": "AP201808241182529387",
      "column": "002004006001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000250128.张静含",
        "11000240930.贾雅希"
      ],
      "indvIsNew": "001",
      "researcher": "张静含,贾雅希",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 532,
      "attachPages": 6,
      "encodeUrl": "WkiGVUSuvmAjtcMCunckEZqS6zgGEvAaCsBRObLFCpI=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHANGHAI",
      "authorID": [
        "11000250128",
        "11000240930"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "吡咯替尼疗效突出，创纪录高效获批上市",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-08-21 00:00:00.000",
      "infoCode": "AP201808211181190929",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0600000000",
      "predictLastYearPe": "60.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1260,
      "attachPages": 9,
      "encodeUrl": "nlLtRY+pFLFK6xBbdY/Bf4zQDSNUwK/U+ljkLGQZwog=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "Expect growth acceleration ahead",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80044865",
      "orgName": "Deutsche Bank AG",
      "orgSName": "德意志银行",
      "publishDate": "2018-08-16 00:00:00.000",
      "infoCode": "AP201808161179546240",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0300000000",
      "predictLastYearPe": "68.1000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000195635.Jack Hu"
      ],
      "indvIsNew": "001",
      "researcher": "Jack Hu",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "85.5000000000",
      "indvAimPriceL": "85.5000000000",
      "attachType": "0",
      "attachSize": 455,
      "attachPages": 11,
      "encodeUrl": "jGDfJRZIQ5jq2K/iZQFazA3THUX9Nq+g6oQvll3GWd0=",
      "sRatingName": "Buy",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000195635"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "吡咯替尼审评完毕，有望快速放量推动业绩高速增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2018-08-15 00:00:00.000",
      "infoCode": "AP201808151179062405",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0600000000",
      "predictLastYearPe": "67.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 550,
      "attachPages": 6,
      "encodeUrl": "Jw6WIWD/ZOStUj9HS5WT1NrKPAjc5RBur3J6ZWPXmuI=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "半年报跟踪：业绩稳定增长，重磅品种陆续步入收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2018-08-15 00:00:00.000",
      "infoCode": "AP201808151178961829",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0500000000",
      "predictLastYearPe": "67.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000173527.李平祝",
        "11000277542.王晓琦"
      ],
      "indvIsNew": "001",
      "researcher": "李平祝,王晓琦",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 798,
      "attachPages": 12,
      "encodeUrl": "Jw6WIWD/ZOStUj9HS5WT1PP9+x8URTFrcLNu5W6YUHs=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000173527",
        "11000277542"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "收入增速符合预期，股权激励费用影响业绩，创新品种逐步推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2018-08-13 00:00:00.000",
      "infoCode": "AP201808131177541805",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0600000000",
      "predictLastYearPe": "63.2000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 597,
      "attachPages": 7,
      "encodeUrl": "WpBgTEoZiwbIftoE9r1LnNGZoXHkhXZiWa4xa+qYE2U=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "中报业绩稳健增长，多款重磅新药进入收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2018-08-13 00:00:00.000",
      "infoCode": "AP201808131177515367",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0500000000",
      "predictLastYearPe": "63.7000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000274747.郑巧"
      ],
      "indvIsNew": "001",
      "researcher": "郑巧",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 467,
      "attachPages": 5,
      "encodeUrl": "WpBgTEoZiwbIftoE9r1LnOm1qP8m9SFtA86qitn0J5c=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000274747"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2018年中报点评：业绩稳健符合预期，创新药即将进入收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2018-08-10 00:00:00.000",
      "infoCode": "AP201808101177027335",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3500000000",
      "predictLastYearPe": "65.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋",
        "11000249425.胡偌碧"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋,胡偌碧",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 455,
      "attachPages": 10,
      "encodeUrl": "Gvxr3wpxVgUAC5SfcZhEGWFgjzcmKwN1oXe1ikLxE2M=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000210529",
        "11000249425"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司业绩符合预期，重磅新药获批在即",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2018-08-10 00:00:00.000",
      "infoCode": "AP201808101176895755",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0600000000",
      "predictLastYearPe": "63.2300000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000172706.李敬雷"
      ],
      "indvIsNew": "001",
      "researcher": "李敬雷",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 960,
      "attachPages": 4,
      "encodeUrl": "Gvxr3wpxVgUAC5SfcZhEGcGAM6siv6RUrB0LqCd2H2E=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000172706"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "收入增长加速，创新品种陆续获批",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-08-10 00:00:00.000",
      "infoCode": "AP201808101176889423",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0600000000",
      "predictLastYearPe": "63.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 810,
      "attachPages": 4,
      "encodeUrl": "Gvxr3wpxVgUAC5SfcZhEGecx/EsLSuOOmfL+bZO6hqI=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "地氟烷获批，进一步丰富麻醉产品线",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-08-07 00:00:00.000",
      "infoCode": "AP201808071175563645",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0600000000",
      "predictLastYearPe": "59.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 804,
      "attachPages": 4,
      "encodeUrl": "EMj0A+D4hLF8wf/nto41Mp+nYIVw2HMkNr1LPYXzJr0=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司一致性评价进入收获季节",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-08-03 00:00:00.000",
      "infoCode": "AP201808031174201112",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0600000000",
      "predictLastYearPe": "66.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 804,
      "attachPages": 4,
      "encodeUrl": "X1unnKWHIdffs7TORUUno6sACb6cIf9eE04UmtQQEoI=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "HHPG-19K formally approved to be made available in the market",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80417743",
      "orgName": "CITIC Securities Company Limited",
      "orgSName": "中信证券经纪(香港)",
      "publishDate": "2018-06-07 00:00:00.000",
      "infoCode": "AP201806071153718439",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0100000000",
      "predictLastYearPe": "73.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000234969.田加强",
        "11000206928.CAO Yang"
      ],
      "indvIsNew": "001",
      "researcher": "田加强,CAO Yang",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 913,
      "attachPages": 4,
      "encodeUrl": "p6xcWLJDsR4PpB9LrScyaYB9BGjKuypow+ZDlMgl55s=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000234969",
        "11000206928"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "19K审批完毕，重磅品种有望近期上市并实现弯道超车",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2018-05-10 00:00:00.000",
      "infoCode": "AP201805101140806127",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "60.7000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 676,
      "attachPages": 6,
      "encodeUrl": "77vvTVrX9e4EUbjLDQI8bIOm7bPtQ1p8T05QuGMAf6k=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "收入增速符合预期，股权激励费用影响业绩，优先审评有望加快PD-1单抗报产进度",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2018-05-02 00:00:00.000",
      "infoCode": "AP201805021134452714",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "59.2000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 534,
      "attachPages": 5,
      "encodeUrl": "UC/gauqKHYHYrvgkKTQ0C0GGzrUDdRsFz3MCP95Vd98=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2018年一季报点评：业绩稳健符合预期，PD-1单抗&瑞马唑仑进入优先审批值得期待",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2018-04-27 00:00:00.000",
      "infoCode": "AP201804271132171472",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3500000000",
      "predictLastYearPe": "62.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋",
        "11000249425.胡偌碧"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋,胡偌碧",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 799,
      "attachPages": 7,
      "encodeUrl": "ryACEUWXGkydGnX4Lomf3YhwlZVoBFxe5UE/LE7jACw=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000210529",
        "11000249425"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "摊销费用影响表观业绩，不改向上发展新周期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-04-27 00:00:00.000",
      "infoCode": "AP201804271132155110",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3700000000",
      "predictLastYearPe": "61.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "93.8000000000",
      "indvAimPriceL": "93.8000000000",
      "attachType": "0",
      "attachSize": 816,
      "attachPages": 4,
      "encodeUrl": "ryACEUWXGkydGnX4Lomf3f4YbDb23/vXdhxCWWL1MhM=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司收入符合预期，重磅新品逐步上市",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2018-04-27 00:00:00.000",
      "infoCode": "AP201804271131991449",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3800000000",
      "predictLastYearPe": "60.8000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000172706.李敬雷"
      ],
      "indvIsNew": "001",
      "researcher": "李敬雷",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 899,
      "attachPages": 4,
      "encodeUrl": "ryACEUWXGkydGnX4Lomf3WDUYPOHNzrpyiHA4Hf8NTQ=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000172706"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "动态分析：业绩符合预期，国内外双线布局将助力公司进一步成长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2018-04-18 00:00:00.000",
      "infoCode": "AP201804181125619978",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3500000000",
      "predictLastYearPe": "60.1000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000232234.王冯"
      ],
      "indvIsNew": "001",
      "researcher": "王冯",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 744,
      "attachPages": 11,
      "encodeUrl": "EId67V7e0Lh+Bcb+rGV1nm5sDD5MTiaD5qqxy8tUkFg=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000232234"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩分析：业绩高于预期；18年关注新上市产品",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80056613",
      "orgName": "北京高华证券有限责任公司",
      "orgSName": "高华证券",
      "publishDate": "2018-04-18 00:00:00.000",
      "infoCode": "AP201804181125536942",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4000000000",
      "predictLastYearPe": "57.9000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000245836.陈子易"
      ],
      "indvIsNew": "001",
      "researcher": "陈子易",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "94.3100000000",
      "indvAimPriceL": "94.3100000000",
      "attachType": "0",
      "attachSize": 376,
      "attachPages": 4,
      "encodeUrl": "EId67V7e0Lh+Bcb+rGV1nlf0dAEkTLa7ycMsWnGuQsU=",
      "sRatingName": "买入",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000245836"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "收入增速超预期，重磅新药将陆续上市",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000155",
      "orgName": "上海证券有限责任公司",
      "orgSName": "上海证券",
      "publishDate": "2018-04-17 00:00:00.000",
      "infoCode": "AP201804171124425220",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "59.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000235631.杜臻雁"
      ],
      "indvIsNew": "001",
      "researcher": "杜臻雁",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 473,
      "attachPages": 4,
      "encodeUrl": "whHwlR2bumvsC0eGuieMXx0o72o7MU+vcanoeRoYIWM=",
      "sRatingName": "增持",
      "sRatingCode": "0203",
      "market": "SHANGHAI",
      "authorID": [
        "11000235631"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩符合预期，研发投入加大推进创新药品上市",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2018-04-16 00:00:00.000",
      "infoCode": "AP201804161123634684",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "57.4000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 702,
      "attachPages": 7,
      "encodeUrl": "PGKWDQ5uZmomyrDiWMkXBEo5hDiBtqrrFIlVWzoXVSE=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2017年报点评：收入增速接近25%超预期，强者“恒”强创新+国际化加速推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2018-04-16 00:00:00.000",
      "infoCode": "AP201804161123452977",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3500000000",
      "predictLastYearPe": "60.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋",
        "11000249425.胡偌碧"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋,胡偌碧",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1418,
      "attachPages": 15,
      "encodeUrl": "PGKWDQ5uZmomyrDiWMkXBBu8M+SZlCb0Sk6peS2VUK4=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000210529",
        "11000249425"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司业绩符合预期，研发持续投入未来可期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2018-04-16 00:00:00.000",
      "infoCode": "AP201804161123404856",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "57.4000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000172706.李敬雷"
      ],
      "indvIsNew": "001",
      "researcher": "李敬雷",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "92.3000000000",
      "indvAimPriceL": "92.3000000000",
      "attachType": "0",
      "attachSize": 913,
      "attachPages": 4,
      "encodeUrl": "PGKWDQ5uZmomyrDiWMkXBPWSacnO92++USHcuqQdFH0=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000172706"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "销售改革驱动增长明显，创新药即将进入收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-04-16 00:00:00.000",
      "infoCode": "AP201804161123392634",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4200000000",
      "predictLastYearPe": "57.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "93.8000000000",
      "indvAimPriceL": "93.8000000000",
      "attachType": "0",
      "attachSize": 803,
      "attachPages": 4,
      "encodeUrl": "PGKWDQ5uZmomyrDiWMkXBCPpAF9/Ojr4yFuIUVWaAw0=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药甲苯磺酸瑞马唑仑药品申请获批：创新药又添重磅品种",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000095",
      "orgName": "国都证券",
      "orgSName": "国都证券",
      "publishDate": "2018-04-16 00:00:00.000",
      "infoCode": "AP201804151123365416",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000175690.肖世俊"
      ],
      "indvIsNew": "001",
      "researcher": "肖世俊",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 232,
      "attachPages": 2,
      "encodeUrl": "KKXNKo2ZLRhE9CBMvEuje2riwDkT1xUHDYtprau6I7Q=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000175690"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "瑞马唑仑超预期报产，或将成为重磅全麻产品",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-03-26 00:00:00.000",
      "infoCode": "AP201803261110516289",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3800000000",
      "predictLastYearPe": "61.4300000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "93.8000000000",
      "indvAimPriceL": "93.8000000000",
      "attachType": "0",
      "attachSize": 1177,
      "attachPages": 7,
      "encodeUrl": "QvPaUT91YfDoTt8souoBbAtcIwWB6of5O6TSzjN6BQ0=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "国内外仿制药双双落地，创新药呼之欲出",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2018-03-05 00:00:00.000",
      "infoCode": "AP201803051098278771",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.6900000000",
      "predictLastYearPe": "43.7000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000172706.李敬雷"
      ],
      "indvIsNew": "001",
      "researcher": "李敬雷",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "92.3000000000",
      "indvAimPriceL": "88.7500000000",
      "attachType": "0",
      "attachSize": 1002,
      "attachPages": 4,
      "encodeUrl": "L0d6UiyvJtuB+IxTO1wj7n92k4L3qSFSNZrSuc7b4aI=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000172706"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "吸入用地氟烷美国首仿上市，制剂出口再传捷报",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000155",
      "orgName": "上海证券有限责任公司",
      "orgSName": "上海证券",
      "publishDate": "2018-03-02 00:00:00.000",
      "infoCode": "AP201803021097734998",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3500000000",
      "predictLastYearPe": "55.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000235631.杜臻雁"
      ],
      "indvIsNew": "001",
      "researcher": "杜臻雁",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 460,
      "attachPages": 4,
      "encodeUrl": "5baDmlWC64CoZncqJqCjqfFnOwS+uBuCgYBUpojw+ck=",
      "sRatingName": "增持",
      "sRatingCode": "0203",
      "market": "SHANGHAI",
      "authorID": [
        "11000235631"
      ],
      "count": 1,
      "orgType": "white"
    }
  ],
  "TotalPage": 7,
  "pageNo": 5,
  "currentYear": 2025
}